Safety Considerations of Adjuvant Therapy in Early Breast Cancer in Postmenopausal Women

Publisher： Karger

E-ISSN： 1423-0232|69|1|1-9

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.1, 2005-09, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant endocrine therapy for postmenopausal women with early stage breast cancer

By Grant Margaret   Rea Daniel W  

Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. : 305-318

Future Medicine

Access to resources Recommend Favorite

Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer

By Ligibel Jennifer A   Winer Eric P  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 89-97

Future Medicine

Access to resources Recommend Favorite

Effect of Adjuvant Tamoxifen Therapy on Thyroid Function in Postmenopausal Women with Breast Cancer

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 43-45

Karger

Access to resources Recommend Favorite

Adjuvant endocrine therapy of premenopausal women with early breast cancer: an overview

By Hubalek Michael  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 7-8, 2010-04 ,pp. : 167-173

Springer Publishing Company

Access to resources Recommend Favorite

Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer

By Bell R.   Lewis J.  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1045-1051

Informa Healthcare

Access to resources Recommend Favorite